Tariq Musa sold $19K of GH
Tariq Musa sold 116 shares of Guardant Health, Inc. (GH) at $163.29 on 2026-07-16 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest concrete fact is the specific sale details (116 shares at $163.29, total $18,941.64) and that it was executed under a pre-arranged Rule 10b5-1 plan.
Market read
Traders may note the planned insider selling, but there is no accompanying fundamental news in the text.
What to watch
The transaction size is small relative to typical institutional flows, and the filing does not disclose any change in business outlook, only the sale mechanics.
Background
The article is a SEC Form 4 insider transaction disclosure for Guardant Health, Inc., reported by director Tariq Musa.
Ticker impact
Guardant Health director Tariq Musa filed a Form 4 open-market sale of 116 shares at $163.29 on 2026-07-16 under a 10b5-1 plan.
Likely negligible immediate price impact; any effect is more sentiment-level than fundamental.
The filing is an insider transaction (not an earnings, guidance, deal, or regulatory event) and the article specifies a pre-arranged 10b5-1 plan, which typically reduces interpretive weight.
Market effects
No clear read-through to biotech/diagnostics sector fundamentals from a small, planned insider sale.
None indicated.
None indicated.
Counterpoint
Even planned 10b5-1 sales can coincide with insider expectations of near-term risk, but the article provides no additional company-specific catalyst.
Key entities
- issuerGuardant Health, Inc.
US-listed company subject of the Form 4 insider transaction disclosure.
- insiderTariq Musa
Director of Guardant Health who reported an open-market sale under a 10b5-1 plan.
